EP3630158
METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE EVENTS IN CANCER THERAPIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.5.2018EP published:
13.7.2022EP application number:
18806547.8
EPO information:
European Patent Register
Max expiry date:
20.5.2038
Title in English:
METHODS OF USE OF SOLUBLE CD24 FOR TREATING IMMUNE RELATED ADVERSE EVENTS IN CANCER THERAPIESLanguage of the patent:
English
Timeline
Today
21.5.2018EP application
13.7.2022EP Publication
Owner
Name:
Oncoimmune, Inc.Address:
9430 Key West Avenue Suite 113, Rockville, Maryland 20850, US
Name:
Children's National Medical CenterAddress:
111 Michigan Avenue N.W., Washington, DC 20010, US
Inventor
Name:
LIU, YangAddress:
Washington District of Columbia 20002, US
Name:
ZHENG, PanAddress:
Washington District of Columbia 20002, US
Name:
DEVENPORT, MartinAddress:
Gaithersburg Maryland 20878, US
Name:
LIU, MingyueAddress:
Baltimore, Maryland 21207, US
Priority
Number:
201762509498 PDate:
22.5.2017Country:
US
Classification
Categories:
A61K 38/17, C07K 14/705